NO20025220L - Ny fremgangsmåte - Google Patents

Ny fremgangsmåte

Info

Publication number
NO20025220L
NO20025220L NO20025220A NO20025220A NO20025220L NO 20025220 L NO20025220 L NO 20025220L NO 20025220 A NO20025220 A NO 20025220A NO 20025220 A NO20025220 A NO 20025220A NO 20025220 L NO20025220 L NO 20025220L
Authority
NO
Norway
Prior art keywords
new procedure
stable
formoterol
copd
rhinitis
Prior art date
Application number
NO20025220A
Other languages
English (en)
Norwegian (no)
Other versions
NO20025220D0 (no
Inventor
Eva Trofast
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9892016&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20025220(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20025220D0 publication Critical patent/NO20025220D0/no
Publication of NO20025220L publication Critical patent/NO20025220L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Catalysts (AREA)
  • Separation By Low-Temperature Treatments (AREA)
  • Saccharide Compounds (AREA)
NO20025220A 2000-05-19 2002-10-31 Ny fremgangsmåte NO20025220L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0012261.4A GB0012261D0 (en) 2000-05-19 2000-05-19 Novel process
PCT/SE2001/001117 WO2001089491A1 (fr) 2000-05-19 2001-05-17 Nouveau procede

Publications (2)

Publication Number Publication Date
NO20025220D0 NO20025220D0 (no) 2002-10-31
NO20025220L true NO20025220L (no) 2002-10-31

Family

ID=9892016

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025220A NO20025220L (no) 2000-05-19 2002-10-31 Ny fremgangsmåte

Country Status (19)

Country Link
US (3) US7179489B2 (fr)
EP (1) EP1289505B1 (fr)
JP (3) JP5739597B2 (fr)
KR (1) KR100799452B1 (fr)
CN (1) CN1245962C (fr)
AT (1) ATE276748T1 (fr)
AU (2) AU2001259006B2 (fr)
BR (1) BRPI0110947B8 (fr)
CA (1) CA2409660C (fr)
DE (1) DE60105807T2 (fr)
ES (1) ES2227190T3 (fr)
GB (1) GB0012261D0 (fr)
IL (2) IL152532A0 (fr)
MX (1) MXPA02011310A (fr)
NO (1) NO20025220L (fr)
NZ (1) NZ522419A (fr)
PT (1) PT1289505E (fr)
WO (1) WO2001089491A1 (fr)
ZA (1) ZA200208710B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
EA007377B1 (ru) 2002-08-21 2006-10-27 Нортон Хелткэа Лтд. Композиции для ингаляции
GB0219511D0 (en) 2002-08-21 2002-10-02 Norton Healthcare Ltd Method of preparing dry powder inhalation compositions
KR20050056222A (ko) * 2002-09-30 2005-06-14 아쿠스피어 인코포레이티드 흡입용 지속 방출형 다공성 미세입자
US7879833B2 (en) 2002-12-12 2011-02-01 Nycomed Gmbh Combination medicament
US6962006B2 (en) * 2002-12-19 2005-11-08 Acusphere, Inc. Methods and apparatus for making particles using spray dryer and in-line jet mill
US20040121003A1 (en) * 2002-12-19 2004-06-24 Acusphere, Inc. Methods for making pharmaceutical formulations comprising deagglomerated microparticles
GB0312148D0 (en) 2003-05-28 2003-07-02 Aventis Pharma Ltd Stabilized pharmaceutical products
GB0315889D0 (en) 2003-07-08 2003-08-13 Aventis Pharma Ltd Stable pharmaceutical products
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
WO2005014044A1 (fr) * 2003-07-29 2005-02-17 Boehringer Ingelheim International Gmbh Medicaments destines a l'inhalation contenant des betamimetiques et un anticholinergique
JP5618452B2 (ja) 2003-09-16 2014-11-05 タケダ ゲゼルシャフト ミット ベシュレンクテル ハフツングＴａｋｅｄａ ＧｍｂＨ 呼吸器疾患の治療のためのシクレソニドの使用
GB0323684D0 (en) 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
WO2005123072A1 (fr) * 2004-06-14 2005-12-29 Sepracor Inc. Procedes et compositions destines au traitement de maladies pulmonaires
EP1848444B1 (fr) 2005-02-10 2016-11-09 Glaxo Group Limited Procedes de fabrication du lactose au moyen de techniques de pre-classification et preparations pharmaceutiques ainsi obtenues
US20070148211A1 (en) * 2005-12-15 2007-06-28 Acusphere, Inc. Processes for making particle-based pharmaceutical formulations for oral administration
US7913223B2 (en) * 2005-12-16 2011-03-22 Dialogic Corporation Method and system for development and use of a user-interface for operations, administration, maintenance and provisioning of a telecommunications system
CN101342155B (zh) * 2007-07-11 2012-01-04 天津帝士力投资控股集团有限公司 一种(r,r)-福莫特罗吸入粉雾剂及其制备方法
EP2100599A1 (fr) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Composition à inhaler comprenant aclidinium pour le traitement de l'asthme et de maladies respiratoires obstructives chroniques
EP2100598A1 (fr) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Composition à inhaler comprenant aclidinium pour le traitement de l'asthme et de maladies respiratoires obstructives chroniques
WO2010144043A1 (fr) * 2009-06-12 2010-12-16 Astrazeneca Ab Nouveau sel 4-méthylbenzènesulphonate et procédé de préparation d'une composition pharmaceutique comprenant le sel
GB0918149D0 (en) 2009-10-16 2009-12-02 Jagotec Ag Improved medicinal aerosol formulation
EP2538922B1 (fr) * 2010-02-25 2016-04-06 Andi-Ventis Limited Formulation de compositions pour le traitement d'états inflammatoires
TR201007250A2 (tr) * 2010-09-01 2012-03-21 Bi̇lgi̇ç Mahmut Selobioz içeren formülasyon.
EP2510928A1 (fr) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium pour l'amélioration du sommeil des patients avec des maldadies respiratoires
WO2013109211A1 (fr) * 2012-01-16 2013-07-25 Mahmut Bilgic Formulations en poudre sèche comprenant du r-formotérol utilisé comme agent actif
WO2013109215A1 (fr) * 2012-01-16 2013-07-25 Mahmut Bilgic Préparation de formulations en poudre sèche comprenant du formotérol
CA2865702C (fr) * 2012-02-28 2020-04-28 Iceutica Holdings Inc. Bvi Compositions pharmaceutiques inhalables
CA3150240A1 (fr) 2019-09-24 2021-04-01 Tomaso GUIDI Formulation de poudre seche pour un inhalateur a poudre seche comprenantune combinaison de particules spheronisees et de particules grossieres, et inhalateur a poudre seche comprenant la formulation

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2514078B2 (ja) * 1988-08-22 1996-07-10 エスエス製薬株式会社 圧縮成型製剤
US5795564A (en) 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
US5874063A (en) * 1991-04-11 1999-02-23 Astra Aktiebolag Pharmaceutical formulation
ES2079743T3 (es) * 1991-07-01 1996-01-16 Gergely Gerhard Tableta para chupar o masticar.
JPH0558911A (ja) * 1991-08-27 1993-03-09 N D Shinyaku Kaihatsu Kenkyusho:Kk 鎮咳去痰剤
CZ288032B6 (cs) * 1991-12-18 2001-04-11 Aktiebolaget Astra Farmaceutický prostředek pro podání inhalací
SE9404080L (sv) * 1993-12-28 1995-06-29 Ciba Geigy Ag Förfarande för framställning av en optiskt ren enantiomer av formoterol
SE9700134D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700136D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9703407D0 (sv) 1997-09-19 1997-09-19 Astra Ab New use
SE9802073D0 (sv) * 1998-06-11 1998-06-11 Astra Ab New use
CN1150895C (zh) 1998-11-13 2004-05-26 杰格研究股份公司 用于吸入给药的干粉
US6034604A (en) * 1999-01-14 2000-03-07 Kaltner; George Deactivation prevention for electronic article surveillance systems
PE20011227A1 (es) 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
GB0012260D0 (en) * 2000-05-19 2000-07-12 Astrazeneca Ab Novel composition

Also Published As

Publication number Publication date
IL219785A (en) 2015-10-29
ZA200208710B (en) 2004-02-10
IL219785A0 (en) 2012-06-28
PT1289505E (pt) 2005-01-31
IL152532A0 (en) 2003-06-24
ATE276748T1 (de) 2004-10-15
BRPI0110947B1 (pt) 2016-12-27
DE60105807D1 (de) 2004-10-28
MXPA02011310A (es) 2003-04-25
CA2409660A1 (fr) 2001-11-29
US20070259048A1 (en) 2007-11-08
CA2409660C (fr) 2011-02-08
JP2013040214A (ja) 2013-02-28
US7670625B2 (en) 2010-03-02
JP2015042693A (ja) 2015-03-05
AU2001259006B2 (en) 2005-03-24
KR20030001514A (ko) 2003-01-06
CN1245962C (zh) 2006-03-22
BRPI0110947B8 (pt) 2021-05-25
AU5900601A (en) 2001-12-03
NO20025220D0 (no) 2002-10-31
WO2001089491A1 (fr) 2001-11-29
US7179489B2 (en) 2007-02-20
JP5739597B2 (ja) 2015-06-24
EP1289505B1 (fr) 2004-09-22
KR100799452B1 (ko) 2008-01-30
CN1429103A (zh) 2003-07-09
ES2227190T3 (es) 2005-04-01
US20030129245A1 (en) 2003-07-10
US20100183729A1 (en) 2010-07-22
DE60105807T2 (de) 2005-11-24
NZ522419A (en) 2003-08-29
EP1289505A1 (fr) 2003-03-12
BR0110947A (pt) 2003-04-29
GB0012261D0 (en) 2000-07-12
JP2003534272A (ja) 2003-11-18

Similar Documents

Publication Publication Date Title
NO20025220D0 (no) Ny fremgangsmÕte
IL152470A0 (en) Pharmaceutical composition comprising micronised formoterol and micronised glucocorticosteroid
IS6444A (is) Pýrimidín karboxamíð nytsamleg sem latar á PDE4 samsætuensím
AU2001295760A1 (en) Pharmaceutical composition comprising resveratrol for treating inflammatory respiratory disorders
DE60120936D1 (de) Behandlung von atemerkrankungen
SE0200356D0 (sv) Novel use
EA200500328A1 (ru) Композиция и лекарственное средство для лечения респираторных заболеваний, аллергических заболеваний, астмы и/или хронических обструктивных заболеваний легких и способ получения лекарственного средства
SG149876A1 (en) Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
SE9900834D0 (sv) Novel combination
MXPA04007294A (es) Composicion para inhalacion.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application